GenSight Biologics S.A. (GSGTF)
USD 0.24
(0.0%)
USD 0.24
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 32.66 Million EUR | 12.03% |
| 2022 | 33.89 Million USD | -14.58% |
| 2021 | 39.67 Million USD | 3.11% |
| 2020 | 38.47 Million USD | 0.16% |
| 2019 | 38.41 Million USD | -9.36% |
| 2018 | 42.38 Million EUR | 28.5% |
| 2017 | 32.98 Million EUR | 26.37% |
| 2016 | 26.1 Million EUR | 40.65% |
| 2015 | 18.55 Million EUR | 175.19% |
| 2014 | 6.74 Million EUR | 137.57% |
| 2013 | 2.83 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 9.01 Million USD | 0.0% |
| 2023 Q2 | 21.06 Million USD | 0.0% |
| 2023 Q4 | 16.1 Million USD | 0.0% |
| 2023 FY | 37.96 Million USD | 12.03% |
| 2022 FY | 33.89 Million USD | -14.58% |
| 2022 Q2 | 16.57 Million USD | 0.0% |
| 2021 FY | 39.67 Million USD | 3.11% |
| 2021 Q2 | 15.62 Million USD | 0.0% |
| 2020 Q4 | 18.39 Million USD | 0.0% |
| 2020 FY | 38.47 Million USD | 0.16% |
| 2020 Q2 | 18.43 Million USD | 0.0% |
| 2019 FY | 38.41 Million USD | -9.36% |
| 2019 Q2 | 21.72 Million USD | 0.0% |
| 2019 Q4 | 17 Million USD | 0.0% |
| 2018 Q2 | 15.39 Million USD | 0.0% |
| 2018 Q4 | 27.3 Million USD | 0.0% |
| 2018 FY | 42.38 Million EUR | 28.5% |
| 2017 FY | 32.98 Million EUR | 26.37% |
| 2016 FY | 26.1 Million EUR | 40.65% |
| 2015 FY | 18.55 Million EUR | 175.19% |
| 2014 FY | 6.74 Million EUR | 137.57% |
| 2013 FY | 2.83 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ContraFect Corporation | 56.88 Million USD | 42.59% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -187374.887% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 130740.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -2334.506% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 62.367% |
| Kadimastem Ltd | 2.41 Million USD | -1255.124% |
| Zenith Capital Corp. | 8.94 Million USD | -265.202% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -1651.798% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -129662.803% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -386.156% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -12378.699% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -2108.619% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 12.335% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -2074.58% |
| Qrons Inc. | 643.67 Thousand USD | -4973.973% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -1967.933% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -1230.174% |
| Accustem Sciences Inc. | 3.74 Million USD | -771.766% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -6039.536% |
| Affymax, Inc. | 39.38 Million USD | 17.077% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 67.12% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -547.753% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -1070.46% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -2345.652% |
| Biomind Labs Inc. | 994.18 Thousand USD | -3185.113% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -200.543% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -1142.996% |
| CytoDyn Inc. | 18.05 Million USD | -80.862% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -10.513% |
| IMV Inc. | 37.7 Million USD | 13.39% |
| Genus plc | 147.7 Million USD | 77.888% |
| Halberd Corporation | 74.84 Thousand USD | -43538.599% |
| Helix BioMedix, Inc. | 1.97 Million USD | -1556.158% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -564.103% |
| LadRx Corporation | 3.81 Million USD | -756.815% |
| Marizyme, Inc. | 19.23 Million USD | -69.752% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -14740.193% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -32.146% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -640.813% |
| Q BioMed Inc. | 3.43 Million USD | -850.35% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -3436.507% |
| Enzolytics Inc. | 2.17 Million USD | -1398.504% |
| CSL Limited | 3.44 Billion USD | 99.053% |
| Skye Bioscience, Inc. | 13.54 Million USD | -141.077% |
| SQZ Biotechnologies Company | 85.61 Million USD | 61.854% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -1494.178% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -272.014% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -18942.732% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -1258.041% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -3028.352% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -291.654% |
| NovAccess Global Inc. | 2.46 Million USD | -1224.003% |
| HST Global, Inc. | 140.9 Thousand USD | -23078.408% |
| SYBLEU INC | 160.87 Thousand USD | -20201.35% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 61.999% |
| Alpha Cognition Inc. | 9.7 Million USD | -236.507% |
| AVAX Technologies, Inc. | 7.31 Million USD | -346.769% |
| Mesoblast Limited | 5.9 Million USD | -453.372% |
| MultiCell Technologies, Inc. | 567.42 USD | -5755777.481% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -1019.937% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -103.994% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -8283.689% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | 85.516% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -1679.744% |
| GB Sciences, Inc. | 1.42 Million USD | -2199.176% |
| argenx SE | 1.53 Billion USD | 97.87% |
| Resverlogix Corp. | 12.71 Million USD | -156.923% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -794.621% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 43.141% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -1756.021% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -859.184% |
| ONE Bio Corp. | 6.44 Million USD | -406.837% |
| Genscript Biotech Corporation | 825.34 Million USD | 96.043% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -1600.239% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -2803.343% |
| Agentix Corp. | 1.37 Million USD | -2280.89% |
| Adynxx, Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 22.97 Million USD | -42.156% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -17895.978% |
| Cell Source, Inc. | 4.32 Million USD | -655.084% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -7760.806% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -3436.507% |
| Itoco Inc. | 919.14 Thousand USD | -3453.31% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -670.571% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -2818.677% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -2200.337% |
| Nascent Biotech, Inc. | 2.22 Million USD | -1364.653% |
| Rebus Holdings, Inc. | 664 Thousand USD | -4818.675% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -1698.141% |
| Mobile Lads Corp. | 554.54 Thousand USD | -5789.502% |
| International Stem Cell Corporation | 5.27 Million USD | -519.617% |
| Bioxytran, Inc. | 3.82 Million USD | -754.941% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -61941.716% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -160446.625% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 9.943% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -1918.541% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -4338.495% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -949.823% |
| Neutra Corp. | 243.82 Thousand USD | -13295.073% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -87.088% |
| PureTech Health plc | 144.59 Million USD | 77.413% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -59.396% |
| IXICO plc | 4.7 Million USD | -593.86% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -271.263% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 72.263% |
| CSL Limited | 3.89 Billion USD | 99.161% |
| Cellectis S.A. | 97.32 Million USD | 66.441% |